Catherine Gerald Mkindi

In the News

Scientists: Target TB interventions on these transmission hotspots

(Dar es Salaam, September 14, 2017). Scientists at Ifakara Health Institute (IHI) have recently adapted a method for identifying tuberculosis (TB) transmission hotpots using a new technique that could revolutionize …

Research Office, Lab Technicians required

IHI is looking for suitably qualified Research Officer and Laboratory Technicians to fill vacant positions in the Laboratory Unit in Bagamoyo. To apply or share, get more details about these …

Recent Projects

Understanding and enhancing approaches to quality improvement in small and medium sized private facilities in sub-Saharan Africa

This is an evaluation study that IHI is conducting in collaboration with London school of hygiene and tropical medicine. The research takes place in the context of an innovative intervention …

Vaccine Delivery Costing Study

As countries drive towards achieving high and equitable coverage of life-saving vaccines, the availability of sustainable, equitable, and predictable financing for vaccine delivery is essential. Over the last two decades, …

Catherine Gerald Mkindi

Research Scientist

Dr. Catherine Mkindi is trained as a Veterinary Doctor at Sokoine University of Agriculture, Morogoro Tanzania. After completion of her Bachelor degree, she joined the same University as a research associate in the Department of Veterinary immunology and worked for the project whose objective was to evaluate the immunological basis of resistance to East Coast Fever in indigenous Zebu cattle breeds as compared to exotic Friesian cross breeds in the same environment.  During this time, she was also involved in animal disease diagnosis and treatment both at the university animal hospital and in the outreach programs in animal farms. Dr. Mkindi joined a master degree in the Sokoine University, after which she was employed and worked as a lecturer of Veterinary Immunology. She extended her horizon in to human immunology research where she did her thesis in malaria immunology, looking at immune responses to liver stage specific peptide antigens in children who are naturally exposed to malaria in malaria endemic areas of Morogoro. Currently Dr. Mkindi is working with Ifakara Health Institute as a Research Scientist in Clinical Immunology, working in phase one malaria clinical trial to describe malaria peptide P27A specific immune responses delivered with Alhydrogel or GLA-SE adjuvants in Tanzanian volunteers. Dr. Mkindi has developed interests into research that bridge between animal and human health, looking at the possibility of transmission of zoonotic infections from wild and domestic animals to humans in a one health approach. She has attracted a DTRA-collaborative research grant with University of California Davis, USA and Sokoine University, Morogoro, aiming at evaluating zoonotic viral sharing among bats, non human primates and people living in high risk transmission interface of Southern Tanzania.


Zoonotic viral sharing among bats, primates and people in high-risk areas in Tanzania

© Ifakara Health Institute (IHI), 2016